A Phase 2 interventional study of Aminolevulinic Acid PDT (ALA) and Vehicle PDT (VEH) in Keratosis, Actinic, sponsored by DUSA Pharmaceuticals, Inc.. Completed at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-03-14.
Sponsored by DUSA Pharmaceuticals, Inc. (part of Sun Pharmaceutical Industries Limited) · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 29 studies testing Aminolevulinic Acid in Keratosis, Actinic — 1 open to participants now, 2 under way, none of them phase 3. Aminolevulinic Acid · Keratosis, Actinic.
Among the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, this one is the 12th largest by enrollment, is one of 2 that started in 2011, is one of 11 in phase 2, and was the 4th registered.
343 studies on the registry are indexed under Keratosis, Actinic; 29 are open to participants now.
Browse Keratosis, Actinic studies →1 of the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic is open now, in 1 country. Recruiting first, the newest first:
Shanghai Dermatology Hospital · Sites in China
Ages 18+
By country, each count listing its studies:
Aminolevulinic Acid: first FDA approval 1999 (LEVULAN), first EMA approval 2007. What it is approved for, and how studies give it, is on its page →
Of the 21 Keratosis, Actinic studies recruiting now, 16 (76%) set no upper age limit and 1 (5%) stops at 75 or younger; none take children under 18; 2 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
29 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 12 · Phase 3 5 · Phase 4 8
First in 1997; this study’s year is marked. 2 started in 2011.
This study's enrollment of 70 is above the median of 60 across 295 interventional studies indexed under Keratosis, Actinic.
Median enrollment 32 across the 29 interventional studies. Of the 24 that completed or were terminated, 15 (63%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 29 have an industry lead sponsor. The 10 most frequent:
This study is registered under DUSA Pharmaceuticals, Inc., one of the names counted as Sun Pharmaceutical Industries Limited. Under that name alone:
DUSA Pharmaceuticals, Inc. is the lead sponsor of 11 studies on the registry; none are open to participants now.
16 studies in Keratosis, Actinic by Sun Pharmaceutical Industries Limited: 3 open now, 3 under way, 2 of them phase 3. Of 12 finished, 8 (67%) have results posted.
Among the 16 studies in Keratosis, Actinic by Sun Pharmaceutical Industries Limited, this one is the 10th largest by enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2011, is one of 7 in phase 2, and was the 3rd registered.
Sun Pharmaceutical Industries Limited’s Keratosis, Actinic studies by the year they started, since 2008.
None of the studies under way reaches primary completion within a year.
Among the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, from their registry updates:
Among Sun Pharmaceutical Industries Limited’s 16 in Keratosis, Actinic:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to determine if Levulan PDT is safe and effective in the treatment of actinic keratoses on the upper arms and hands.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
use of the following topical preparations on the extremities to be treated:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Biopsy and archival tissue
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Aminolevulinic Acid PDT (ALA)
Drug: Vehicle PDT (VEH)
20% ALA applied to upper extremities for 3 hours prior to 10 J/cm2 blue light
Also known as: Levulan Kerastick
Levulan Kerastick containing vehicle ingredients only. Vehicle solution applied to upper extremities 3 hours prior to 10 J/cm2 blue light
Lesion Clearance Rate
Clearance rate for all lesions
Time frame: Week 12
Lesion Clearance Rate
Time frame: Week 8
Complete Clearance Rate
proportion of subjects with a count of zero lesions in the treatment area
Time frame: Week 8
Complete Clearance Rate
proportion of subjects with a count of zero lesions in the treatment area
Time frame: Week 12
Partial Clearance Rate
proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
Time frame: Baseline and Week 8
Partial Clearance Rate
proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
Time frame: Baseline and Week 12
Subject Satisfaction Score
Subject satisfaction score 1. = Excellent (very satisfied) 2. = Good (moderately satisfied) 3. = Fair (slightly satisfied) 4. = Poor (not satisfied at all)
Time frame: Week 12
Hyperpigmentation at Baseline
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
Time frame: Baseline
Hyperpigmentation at Visit 3
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
Time frame: 2 weeks after PDT #1
Hyperpigmentation at Visit 4
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
Time frame: 8 weeks after PDT #1
Hyperpigmentation at Visit 5
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
Time frame: 12 weeks after PDT #1
Hypopigmentation at Baseline
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation
Time frame: Baseline
Hypopigmentation at Visit 3
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation
Time frame: 2 Weeks after PDT #1
Hypopigmentation at Visit 4
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation
Time frame: 8 Weeks after PDT #1
Hypopigmentation at Visit 5
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation
Time frame: 12 Weeks after PDT #1
Erythema at Baseline
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: Baseline
Erythema Post-Light Treatment
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: 5 Minutes after PDT #1
Erythema at Visit 3
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: 2 Weeks after PDT #1
Erythema at Visit 4
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: 8 Weeks after PDT #1
Erythema at Visit 5
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
Time frame: 12 Weeks after PDT #1
Edema at Baseline
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: Baseline
Edema Post-Light Treatment
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: 5 Minutes after PDT #1
Edema at Visit 3
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: 2 Weeks after PDT #1
Edema at Visit 4
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: 8 Weeks after PDT #1
Edema at Visit 5
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
Time frame: 12 Weeks after PDT #1
Stinging/Burning at Baseline
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: Baseline
Stinging/Burning During Light Treatment
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: During PDT #1
Stinging/Burning Post Light Treatment
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: 5 minutes after PDT #1
Stinging/Burning at Visit 3
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: 2 Weeks after PDT #1
Stinging/Burning at Visit 4
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: 8 Weeks after PDT #1
Stinging/Burning at Visit 5
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
Time frame: 12 Weeks after PDT #1
Scaling and Dryness at Baseline
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
Time frame: Baseline
Scaling and Dryness at Visit 3
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
Time frame: 2 Weeks Post PDT #1
Scaling and Dryness at Visit 4
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
Time frame: 8 Weeks Post PDT #1
Scaling and Dryness at Visit 5
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
Time frame: 12 Weeks Post PDT #1
OOZING/VESICULATION/CRUSTING at Baseline
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
Time frame: Baseline
OOZING/VESICULATION/CRUSTING at Visit 3
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
Time frame: Week 2 after PDT #1
OOZING/VESICULATION/CRUSTING at Visit 4
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
Time frame: 8 Weeks after PDT #1
OOZING/VESICULATION/CRUSTING at Visit 5
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
Time frame: 12 Weeks after PDT #1
Recruitment period was from 28November2011 - 4April2012 at 3 medical clinics in the U.S.
| Milestone | Aminolevulinic Acid | Vehicle |
|---|---|---|
| Started | 35 | 35 |
| Completed | 34 | 35 |
| Not completed | 1 | 0 |
| Withdrew: Withdrawal by subject | 1 | 0 |
Clearance rate for all lesions
| percentage of lesions cleared | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Lesion Clearance Rate | 88.7 ± 25.1 | 70.0 ± 31.1 | 16.7 ± 27.6 | 5.6 ± 26.8 |
| percentage of lesions cleared | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Lesion Clearance Rate | 75.0 ± 34.6 | 47.4 ± 30.7 | 3.3 ± 28.7 | 6.3 ± 25.8 |
proportion of subjects with a count of zero lesions in the treatment area
| arms 100% cleared | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Complete Clearance Rate | 8 | 4 | 0 | 0 |
proportion of subjects with a count of zero lesions in the treatment area
| arms 100% cleared | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Complete Clearance Rate | 12 | 7 | 0 | 1 |
proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
| arms >75% cleared | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Partial Clearance Rate | 18 | 5 | 1 | 2 |
proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.
| arms >75% cleared | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Partial Clearance Rate | 21 | 15 | 3 | 2 |
Subject satisfaction score 1. = Excellent (very satisfied) 2. = Good (moderately satisfied) 3. = Fair (slightly satisfied) 4. = Poor (not satisfied at all)
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Very satisfied | 13 | 7 | 3 | 1 |
| Moderately satisfied | 16 | 14 | 5 | 5 |
| Slightly satisfied | 3 | 8 | 7 | 9 |
| Not satisfied | 3 | 6 | 20 | 20 |
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 5 | 5 | 1 | 1 |
| Grade 1 (light) | 20 | 19 | 23 | 23 |
| Grade 2 (moderate - small) | 9 | 10 | 8 | 8 |
| Grade 3 (moderate - moderate) | 1 | 1 | 3 | 3 |
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 4 | 4 | 1 | 1 |
| Grade 1 (light) | 19 | 20 | 21 | 21 |
| Grade 2 (moderate - small) | 9 | 10 | 10 | 10 |
| Grade 3 (moderate - moderate) | 2 | 1 | 3 | 3 |
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 2 | 2 | 0 | 0 |
| Grade 1 (light) | 24 | 21 | 19 | 17 |
| Grade 2 (moderate - small) | 8 | 11 | 11 | 13 |
| Grade 3 (moderate - moderate) | 1 | 1 | 4 | 4 |
HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 2 | 2 | 0 | 0 |
| Grade 1 (light) | 25 | 23 | 20 | 20 |
| Grade 2 (moderate - small) | 6 | 8 | 11 | 11 |
| Grade 3 (moderate - moderate) | 0 | 0 | 4 | 4 |
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 9 | 9 | 8 | 8 |
| Grade 1 (light) | 21 | 21 | 24 | 24 |
| Grade 2 (moderate - small) | 5 | 5 | 2 | 2 |
| Grade 3 (moderate - moderate) | 0 | 0 | 1 | 1 |
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 10 | 10 | 7 | 7 |
| Grade 1 (light) | 20 | 20 | 26 | 26 |
| Grade 2 (moderate - small) | 4 | 5 | 1 | 1 |
| Grade 3 (moderate - moderate) | 0 | 0 | 1 | 1 |
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 13 | 10 | 9 | 9 |
| Grade 1 (light) | 18 | 21 | 23 | 23 |
| Grade 2 (moderate - small) | 3 | 4 | 1 | 1 |
| Grade 3 (moderate - moderate) | 1 | 0 | 1 | 1 |
HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 10 | 8 | 12 | 11 |
| Grade 1 (light) | 22 | 24 | 21 | 22 |
| Grade 2 (moderate - small) | 1 | 1 | 1 | 1 |
| Grade 3 (moderate - moderate) | 0 | 0 | 1 | 1 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 10 | 10 | 12 | 12 |
| Grade 1 (minimal) | 16 | 16 | 13 | 12 |
| Grade 2 (mild) | 8 | 9 | 9 | 10 |
| Grade 3 (moderate) | 1 | 0 | 1 | 1 |
| Grade 4 (severe) | 0 | 0 | 0 | 0 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 0 | 0 | 4 | 4 |
| Grade 1 (minimal) | 0 | 4 | 11 | 15 |
| Grade 2 (mild) | 7 | 19 | 17 | 13 |
| Grade 3 (moderate) | 21 | 10 | 3 | 3 |
| Grade 4 (severe) | 7 | 2 | 0 | 0 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 0 | 4 | 10 | 10 |
| Grade 1 (minimal) | 8 | 14 | 15 | 14 |
| Grade 2 (mild) | 14 | 15 | 9 | 10 |
| Grade 3 (moderate) | 12 | 2 | 1 | 1 |
| Grade 4 (severe) | 1 | 0 | 0 | 0 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 7 | 6 | 10 | 11 |
| Grade 1 (minimal) | 17 | 20 | 16 | 15 |
| Grade 2 (mild) | 9 | 9 | 7 | 7 |
| Grade 3 (moderate) | 2 | 0 | 1 | 1 |
| Grade 4 (severe) | 0 | 0 | 0 | 0 |
Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 9 | 7 | 11 | 12 |
| Grade 1 (minimal) | 7 | 12 | 14 | 14 |
| Grade 2 (mild) | 16 | 14 | 10 | 9 |
| Grade 3 (moderate) | 1 | 0 | 0 | 0 |
| Grade 4 (severe) | 0 | 0 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 35 | 35 | 35 | 35 |
| Grade 1 (minimal) | 0 | 0 | 0 | 0 |
| Grade 2 (mild) | 0 | 0 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 28 | 33 | 34 | 34 |
| Grade 1 (minimal) | 5 | 2 | 1 | 1 |
| Grade 2 (mild) | 2 | 0 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 27 | 34 | 35 | 35 |
| Grade 1 (minimal) | 5 | 1 | 0 | 0 |
| Grade 2 (mild) | 3 | 0 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 35 | 35 | 34 | 34 |
| Grade 1 (minimal) | 0 | 0 | 0 | 0 |
| Grade 2 (mild) | 0 | 0 | 0 | 0 |
EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 33 | 33 | 35 | 35 |
| Grade 1 (minimal) | 0 | 0 | 0 | 0 |
| Grade 2 (mild) | 0 | 0 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 35 | 35 | 35 | 35 |
| Grade 1 (mild) | 0 | 0 | 0 | 0 |
| Grade 2 (moderate) | 0 | 0 | 0 | 0 |
| Grade 3 (severe) | 0 | 0 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 0 | 0 | 29 | 29 |
| Grade 1 (mild) | 5 | 20 | 6 | 6 |
| Grade 2 (moderate) | 21 | 12 | 0 | 0 |
| Grade 3 (severe) | 9 | 3 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 0 | 2 | 30 | 33 |
| Grade 1 (mild) | 7 | 22 | 5 | 2 |
| Grade 2 (moderate) | 21 | 10 | 0 | 0 |
| Grade 3 (severe) | 7 | 1 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 31 | 35 | 35 | 35 |
| Grade 1 (mild) | 4 | 0 | 0 | 0 |
| Grade 2 (moderate) | 0 | 0 | 0 | 0 |
| Grade 3 (severe) | 0 | 0 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 35 | 35 | 34 | 34 |
| Grade 1 (mild) | 0 | 0 | 0 | 0 |
| Grade 2 (moderate) | 0 | 0 | 0 | 0 |
| Grade 3 (severe) | 0 | 0 | 0 | 0 |
STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 33 | 33 | 35 | 35 |
| Grade 1 (mild) | 0 | 0 | 0 | 0 |
| Grade 2 (moderate) | 0 | 0 | 0 | 0 |
| Grade 3 (severe) | 0 | 0 | 0 | 0 |
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 16 | 16 | 17 | 17 |
| Grade 1 (minimal) | 15 | 15 | 13 | 13 |
| Grade 2 (mild) | 2 | 2 | 4 | 4 |
| Grade 3 (moderate) | 2 | 2 | 1 | 1 |
| Grade 4 (severe) | 0 | 0 | 0 | 0 |
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 3 | 5 | 10 | 11 |
| Grade 1 (minimal) | 5 | 17 | 20 | 19 |
| Grade 2 (mild) | 5 | 10 | 3 | 3 |
| Grade 3 (moderate) | 21 | 3 | 2 | 2 |
| Grade 4 (severe) | 1 | 0 | 0 | 0 |
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 16 | 17 | 14 | 14 |
| Grade 1 (minimal) | 14 | 12 | 14 | 14 |
| Grade 2 (mild) | 4 | 5 | 3 | 3 |
| Grade 3 (moderate) | 1 | 1 | 3 | 3 |
| Grade 4 (severe) | 0 | 0 | 0 | 0 |
SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 18 | 17 | 12 | 12 |
| Grade 1 (minimal) | 12 | 13 | 17 | 17 |
| Grade 2 (mild) | 2 | 2 | 5 | 5 |
| Grade 3 (moderate) | 1 | 1 | 1 | 1 |
| Grade 4 (severe) | 0 | 0 | 0 | 0 |
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 35 | 35 | 35 | 35 |
| Grade 1 (minimal) | 0 | 0 | 0 | 0 |
| Grade 2 (mild) | 0 | 0 | 0 | 0 |
| Grade 3 (moderate) | 0 | 0 | 0 | 0 |
| Grade 4 (severe) | 0 | 0 | 0 | 0 |
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 33 | 34 | 34 | 34 |
| Grade 1 (minimal) | 1 | 0 | 1 | 1 |
| Grade 2 (mild) | 0 | 1 | 0 | 0 |
| Grade 3 (moderate) | 1 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 |
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 35 | 35 | 34 | 34 |
| Grade 1 (minimal) | 0 | 0 | 0 | 0 |
| Grade 2 (mild) | 0 | 0 | 0 | 0 |
| Grade 3 (moderate) | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 |
OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above
| participants | ALA+OCC | ALA-OCC | VEH+OCC | VEH-OCC |
|---|---|---|---|---|
| Grade 0 (none) | 33 | 32 | 35 | 35 |
| Grade 1 (minimal) | 0 | 1 | 0 | 0 |
| Grade 2 (mild) | 0 | 0 | 0 | 0 |
| Grade 3 (moderate) | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 |
Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Aminolevulinic Acid | — | 0/35 (0%) | 17/35 (48.6%) |
| Vehicle | — | 0/35 (0%) | 5/35 (14.3%) |
| Event | Aminolevulinic Acid | Vehicle |
|---|---|---|
| PainSkin and subcutaneous tissue disorders | 9/35 | 0/35 |
| Squamous cell carcinomaNeoplasms benign, malignant and unspecified (incl cysts and polyps) | 4/35 | 0/35 |
| Upper respiratory tract infectionInfections and infestations | 2/35 | 1/35 |
| Wound infectionInfections and infestations | 0/35 | 2/35 |
| Actinic keratosisSkin and subcutaneous tissue disorders | 0/35 | 2/35 |
| ItchingSkin and subcutaneous tissue disorders | 2/35 | 0/35 |
| SwellingSkin and subcutaneous tissue disorders | 2/35 | 0/35 |
| Age Continuous(years) | Aminolevulinic Acid | Vehicle | Total |
|---|---|---|---|
| Mean | 62.1 ± 9.96 | 65.6 ± 9.30 | 63.8 ± 9.72 |
| Sex: Female, Male(Participants) | Aminolevulinic Acid | Vehicle | Total |
|---|---|---|---|
| Female | 13 | 12 | 25 |
| Male | 22 | 23 | 45 |
| Ethnicity (NIH/OMB)(Participants) | Aminolevulinic Acid | Vehicle | Total |
|---|---|---|---|
| Hispanic or Latino | 0 | 0 | 0 |
| Not Hispanic or Latino | 35 | 35 | 70 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Aminolevulinic Acid | Vehicle | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 |
| White | 35 | 35 | 70 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Region of Enrollment(participants) | Aminolevulinic Acid | Vehicle | Total |
|---|---|---|---|
| United States | 35 | 35 | 70 |
The record gives a start of Nov 2011, a primary completion of Jul 2012 and a completion of Jul 2012. It does not say whether these dates are actual or estimated.
Results were first posted in Feb 2013, 7 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Aminolevulinic Acid